Cargando…
Optimization of CRISPR–Cas system for clinical cancer therapy
Cancer is a genetic disease caused by alterations in genome and epigenome and is one of the leading causes for death worldwide. The exploration of disease development and therapeutic strategies at the genetic level have become the key to the treatment of cancer and other genetic diseases. The functi...
Autores principales: | Meng, Xiang, Wu, Tian‐gang, Lou, Qiu‐yue, Niu, Kai‐yuan, Jiang, Lei, Xiao, Qing‐zhong, Xu, Tao, Zhang, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013785/ https://www.ncbi.nlm.nih.gov/pubmed/36925702 http://dx.doi.org/10.1002/btm2.10474 |
Ejemplares similares
-
Optimization of Genome Engineering Approaches with the CRISPR/Cas9 System
por: Li, Kai, et al.
Publicado: (2014) -
Carrier strategies boost the application of CRISPR/Cas system in gene therapy
por: Xu, Zunkai, et al.
Publicado: (2022) -
Current advances of CRISPR-Cas technology in cell therapy
por: Qiu, Hou-Yuan, et al.
Publicado: (2022) -
CRISPR/Cas9 Systems for the Development of Saccharomyces cerevisiae Cell Factories
por: Meng, Jie, et al.
Publicado: (2020) -
Improved Strategies for CRISPR-Cas12-based Nucleic Acids Detection
por: Qiu, Miao, et al.
Publicado: (2022)